Allison Dorval - Net Worth and Insider Trading

Allison Dorval Net Worth

The estimated net worth of Allison Dorval is at least $4 Million dollars as of 2024-04-29. Allison Dorval is the CFO of Insulet Corp and owns about 22,342 shares of Insulet Corp (PODD) stock worth over $4 Million. Allison Dorval is the CFO of Voyager Therapeutics Inc and owns about 45,894 shares of Voyager Therapeutics Inc (VYGR) stock worth over $349,712. Allison Dorval is also the Director of Puma Biotechnology Inc and owns about 44,000 shares of Puma Biotechnology Inc (PBYI) stock worth over $220,880. Besides these, Allison Dorval also holds Verve Therapeutics Inc (VERV) . Details can be seen in Allison Dorval's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Allison Dorval has not made any transactions after 2023-11-29 and currently still holds the listed stock(s).

Transaction Summary of Allison Dorval

To

Allison Dorval Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Allison Dorval owns 5 companies in total, including Voyager Therapeutics Inc (VYGR) , Insulet Corp (PODD) , and Puma Biotechnology Inc (PBYI) among others .

Click here to see the complete history of Allison Dorval’s form 4 insider trades.

Insider Ownership Summary of Allison Dorval

Ticker Comapny Transaction Date Type of Owner
VYGR Voyager Therapeutics Inc 2021-02-11 Vice President & Finance
PODD Insulet Corp 2014-11-06 Chief Financial Officer
PBYI Puma Biotechnology Inc 2023-06-13 director
AVTE Aerovate Therapeutics Inc 2021-07-15 director
VERV Verve Therapeutics Inc 2023-11-29 Chief Financial Officer

Allison Dorval Latest Holdings Summary

Allison Dorval currently owns a total of 4 stocks. Among these stocks, Allison Dorval owns 22,342 shares of Insulet Corp (PODD) as of November 6, 2014, with a value of $4 Million and a weighting of 86.18%. Allison Dorval owns 45,894 shares of Voyager Therapeutics Inc (VYGR) as of February 11, 2021, with a value of $349,712 and a weighting of 8.12%. Allison Dorval also owns 44,000 shares of Puma Biotechnology Inc (PBYI) as of June 13, 2023, with a value of $220,880 and a weighting of 5.13%. The other 1 stocks Verve Therapeutics Inc (VERV) have a combined weighting of 0.58% among all his current holdings.

Latest Holdings of Allison Dorval

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PODD Insulet Corp 2014-11-06 22,342 166.19 3,713,017
VYGR Voyager Therapeutics Inc 2021-02-11 45,894 7.62 349,712
PBYI Puma Biotechnology Inc 2023-06-13 44,000 5.02 220,880
VERV Verve Therapeutics Inc 2023-11-29 4,060 6.16 25,010

Holding Weightings of Allison Dorval


Allison Dorval Form 4 Trading Tracker

According to the SEC Form 4 filings, Allison Dorval has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 0 shares on November 6, 2014, which brought Allison Dorval around $0.

According to the SEC Form 4 filings, Allison Dorval has made a total of 3 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Voyager Therapeutics Inc is the sale of 3,186 shares on February 11, 2021, which brought Allison Dorval around $24,054.

According to the SEC Form 4 filings, Allison Dorval has made a total of 1 transactions in Puma Biotechnology Inc (PBYI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Puma Biotechnology Inc is the sale of 10,000 shares on June 13, 2023, which brought Allison Dorval around $34,500.

More details on Allison Dorval's insider transactions can be found in the Insider Trading History of Allison Dorval table.

Insider Trading History of Allison Dorval

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Allison Dorval Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Allison Dorval Ownership Network

Ownership Network List of Allison Dorval

No Data

Ownership Network Relation of Allison Dorval


Allison Dorval Owned Company Details

What does Voyager Therapeutics Inc do?

Who are the key executives at Voyager Therapeutics Inc?

Allison Dorval is the Vice President & Finance of Voyager Therapeutics Inc. Other key executives at Voyager Therapeutics Inc include Chief Operating Officer Robin Swartz , Chief Scientific Officer Todd Alfred Carter , and Chief Financial Officer Peter P. Pfreundschuh .

Voyager Therapeutics Inc (VYGR) Insider Trades Summary

Over the past 18 months, Allison Dorval made no insider transaction in Voyager Therapeutics Inc (VYGR). Other recent insider transactions involving Voyager Therapeutics Inc (VYGR) include a net sale of 26,455 shares made by Todd Alfred Carter , a net sale of 30,340 shares made by Robin Swartz , and a net sale of 743,642 shares made by Third Rock Ventures Iii, L.p. .

In summary, during the past 3 months, insiders sold 38,202 shares of Voyager Therapeutics Inc (VYGR) in total and bought 0 shares, with a net sale of 38,202 shares. During the past 18 months, 1,765,516 shares of Voyager Therapeutics Inc (VYGR) were sold and 4,395,588 shares were bought by its insiders, resulting in a net purchase of 2,630,072 shares.

Voyager Therapeutics Inc (VYGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Voyager Therapeutics Inc Insider Transactions

No Available Data

Allison Dorval Mailing Address

Above is the net worth, insider trading, and ownership report for Allison Dorval. You might contact Allison Dorval via mailing address: C/o Insulet Corporation, 600 Technology Park Drive, Suite 200, Billerica Ma 01821.

Discussions on Allison Dorval

No discussions yet.